The role of free radicals in the pathophysiology of muscular dystrophy.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of applied physiology

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/JAPPLPHYSIOL.01145.2006PMID 17095633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex

  2006cited by this paper
• Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion

  2006cited by this paper
• Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses.

  2006cited by this paper
• Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium.

  2005influential reference
• Lipid imaging by gold cluster time-of-flight secondary ion mass spectrometry: application to Duchenne muscular dystrophy Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M500058-JLR200

  2005cited by this paper
• NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology

  2005cited by this paper
• Functional nitric oxide synthase mislocalization in cardiomyopathy.

  2004cited by this paper
• Evolving Therapeutic Strategies for Duchenne Muscular Dystrophy: Targeting Downstream Events

  2004cited by this paper
• Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy.

  2004cited by this paper
• Nitric oxide synthase activity is required for postsynaptic differentiation of the embryonic neuromuscular junction.

  2004cited by this paper
• Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins.

  2004cited by this paper
• Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro

  2003cited by this paper
• Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle.

  2003cited by this paper
• The role of nitric oxide signaling in the formation of the neuromuscular junction

  2003cited by this paper
• Inhibitory Effect of Vitamin E Administration on the Progression of Liver Regeneration Induced by Partial Hepatectomy in Rats

  2003cited by this paper
• The Heart in Human Dystrophinopathies

  2003cited by this paper
• Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy.

  2002cited by this paper
• 1-Syntrophin–deficient skeletal muscle exhibits hypertrophy and aberrant formation of neuromuscular junctions during regeneration

  2002cited by this paper
• Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy

  2002cited by this paper
• Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide.

  2002cited by this paper
• Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1.

  2002cited by this paper
• Adult dystrophic (mdx) endplates exhibit reduced quantal size and enhanced quantal variation

  2001cited by this paper
• The susceptibility of muscle cells to oxidative stress is independent of nitric oxide synthase expression

  2001cited by this paper
• Soluble guanylyl cyclase is localized at the neuromuscular junction in human skeletal muscle

  2001cited by this paper
• A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

  2001influential reference
• Physiology of nitric oxide in skeletal muscle.

  2001cited by this paper
• Role of nitric oxide in the pathogenesis of muscular dystrophies: A “two hit” hypothesis of the cause of muscle necrosis

  2001cited by this paper
• Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure.

  2000cited by this paper
• Dystrophin mutations predict cellular susceptibility to oxidative stress

  2000cited by this paper
• Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E.

  2000cited by this paper
• Nitric oxide is a downstream mediator of agrin-induced acetylcholine receptor aggregation.

  2000cited by this paper
• Nitric oxide modulates the catalytic activity of myeloperoxidase.

  2000cited by this paper
• Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin--glycoprotein complex.

  2000cited by this paper
• A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells.

  2000cited by this paper
• Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy.

  2000cited by this paper
• Absence of α-Syntrophin Leads to Structurally Aberrant Neuromuscular Synapses Deficient in Utrophin

  2000cited by this paper
• Nitric Oxide-induced S-Glutathionylation and Inactivation of Glyceraldehyde-3-phosphate Dehydrogenase*

  1999cited by this paper
• Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.

  1999cited by this paper
• Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy.

  1999cited by this paper
• Overexpression of copper/zinc superoxide dismutase: A novel cause of murine muscular dystrophy

  1998cited by this paper
• Glyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite.

  1998cited by this paper
• The effect of age and temperature on MDX muscle fatigue

  1998cited by this paper
• α‐tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells

  1998cited by this paper
• Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state.

  1998cited by this paper
• Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing.

  1998cited by this paper
• mdx muscle pathology is independent of nNOS perturbation.

  1998cited by this paper
• NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R.

  1998cited by this paper
• Long- and short-termd-α-tocopherol supplementation inhibits liver collagen α1(Ι) gene expression.

  1998cited by this paper
• alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells.

  1998cited by this paper
• γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin

  1998cited by this paper
• Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice

  1998cited by this paper
• NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R.

  1998cited by this paper
• Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle.

  1998cited by this paper
• Muscle cells from mdx mice have an increased susceptibility to oxidative stress.

  1998cited by this paper
• Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle.

  1998cited by this paper
• Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle.

  1998cited by this paper
• Topographic comparison of subneural apparatuses at neuromuscular junctions in normal and dystrophic (mdx) mice: a scanning electron microscope study.

  1997cited by this paper
• Oxidative damage and fibrogenesis.

  1997cited by this paper
• Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy.

  1997cited by this paper
• Extraocular, limb and diaphragm muscle group-specific antioxidant enzyme activity patterns in control and mdx mice.

  1996cited by this paper
• Nitric oxide synthase and cyclic GMP-dependent protein kinase concentrated at the neuromuscular endplate.

  1996cited by this paper
• Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy.

  1996cited by this paper
• Modulation of Superoxide-dependent Oxidation and Hydroxylation Reactions by Nitric Oxide (*)

  1996cited by this paper
• Purine and carnitine metabolism in muscle of patients with Duchenne muscular dystrophy.

  1995cited by this paper
• Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.

  1995cited by this paper
• Nitric oxide as a messenger molecule for myoblast fusion.

  1994cited by this paper
• Nitric oxide-mediated apoptosis in murine peritoneal macrophages.

  1993cited by this paper
• Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

  1993cited by this paper
• Potential oxyradical damage and energy status in individual muscle fibres from degenerating muscle diseases.

  1992cited by this paper
• Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase.

  1992cited by this paper
• Echocardiographic evaluation of fibrous replacement in the myocardium of patients with Duchenne muscular dystrophy.

  1991cited by this paper
• Structure and function of the neuromuscular junction in young adultmdx mice

  1991cited by this paper
• Therapeutic possibilities of chronic low frequency electrical stimulation in children with Duchenne muscular dystrophy.

  1990cited by this paper
• Skeletal muscle antioxidant enzyme levels in rats after simulated weightlessness, exercise and dobutamine.

  1989cited by this paper
• Association of dystrophin and an integral membrane glycoprotein

  1989cited by this paper
• Clinical and molecular studies in Duchenne muscular dystrophy.

  1989cited by this paper
• Clinical and molecular studies in Duchenne muscular dystrophy.

  1989cited by this paper
• Lipid peroxide and antioxidant enzymes in muscle and nonmuscle of dystrophic mouse

  1989cited by this paper
• EMG computerized analysis of localized fatigue in duchenne muscular dystrophy

  1988cited by this paper
• A quantitative study of myonuclear and satellite cell nuclear size in Duchenne's muscular dystrophy, polymyositis and normal human skeletal muscle

  1988cited by this paper
• The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle

  1988cited by this paper
• The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates.

  1987cited by this paper
• Practical analysis of variability of muscle function measurements in duchenne muscular dystrophy

  1987cited by this paper
• Effect of Duchenne muscular dystrophy on enzymes of energy metabolism in individual muscle fibers.

  1987cited by this paper
• Plasma antioxidants and lipid peroxidation products in Duchenne muscular dystrophy.

  1986cited by this paper
• Responses of muscles of patients with Duchenne muscular dystrophy to chronic electrical stimulation.

  1986cited by this paper
• Selenium Supplementation in X‐linked Muscular Dystrophy

  1985cited by this paper
• Lipid peroxidation in children with Duchenne's hereditary muscular dystrophy

  1984cited by this paper
• Techniques for studying free radical damage in muscular dystrophy.

  1984cited by this paper
• [Lipid peroxidation in children with Duchenne's hereditary myopathy].

  1984cited by this paper
• Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originates.

  1983cited by this paper
• A quantitative study of the muscle satellite cells in various neuromuscular disorders.

  1983cited by this paper
• Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation

  1983cited by this paper
• Drug trial of superoxide dismutase in Duchenne's muscular dystrophy.

  1982influential reference
• Catalase, superoxide dismutase, glutathione reductase and thiobarbituric acid-reactive products in normal and dystrophic human muscle.

  1979cited by this paper
• Quantitative ultrastructural study of muscle satellite cells in Duchenne dystrophy

  1979cited by this paper
• Duchenne Muscular Dystrophy: Functional Ischemia Reproduces Its Characteristic Lesions

  1971cited by this paper
• Tocopherol deficiency in man.

  1967cited by this paper
• Tocopherol deficiency in man.

  1965cited by this paper
• On the classification, natural history and treatment of the myopathies.

  1954cited by this paper

• Transcriptomic profiling of skeletal muscle in the DMDmdx rat model of Duchenne muscular dystrophy

  2025cites this paper
• VBIT-4 Rescues Mitochondrial Dysfunction and Reduces Skeletal Muscle Degeneration in a Severe Model of Duchenne Muscular Dystrophy

  2025cites this paper
• Mitochondria and Reactive Oxygen Species: The Therapeutic Balance of Powers for Duchenne Muscular Dystrophy

  2024cites this paper
• Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins

  2024cites this paper
• Therapeutic Strategy and Clinical Path of Facioscapulohumeral Muscular Dystrophy: Review of the Current Literature

  2024cites this paper
• Nutritional Issues among Children with Duchenne Muscular Dystrophy—Incidence of Deficiency and Excess Body Mass

  2024cites this paper
• Febuxostat ameliorates muscle degeneration and movement disorder of the dystrophin mutant model in Caenorhabditis elegans

  2023cites this paper
• From amino-acid to disease: the effects of oxidation on actin-myosin interactions in muscle

  2023cites this paper
• Reactive oxygen species downregulate dystroglycans in the megakaryocytes of rats with arterial hypertension.

  2023cites this paper
• Regulation of A-to-I RNA editing and stop codon recoding to control selenoprotein expression during skeletal myogenesis

  2022cites this paper
• Natural Compounds That Enhance Motor Function in a Mouse Model of Muscle Fatigue

  2022cites this paper
• Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target

  2022cites this paper
• Intertubular morphometric and ultrastructural testes analyses in mdx mice

  2022cites this paper
• Interplay between mitochondria and reactive oxygen and nitrogen species in metabolic adaptation to hypoxia in facioscapulohumeral muscular dystrophy: potential therapeutic targets

  2021cites this paper
• A necessary role of DNMT3A in endurance exercise by suppressing ALDH1L1‐mediated oxidative stress

  2021cites this paper
• Tetrahydrobiopterin synthesis and metabolism is impaired in dystrophin‐deficient mdx mice and humans

  2021cites this paper
• Antioxidants in olive oil phenolics: a focus on myoblasts

  2021cites this paper
• Shared and Distinct Mechanisms of Skeletal Muscle Atrophy: A Narrative Review.

  2021cites this paper
• Confounding Roles of ER Stress and the Unfolded Protein Response in Skeletal Muscle Atrophy

  2021cites this paper
• Effect of epicatechin on skeletal muscle.

  2021cites this paper
• The role of Nrf2 in acute and chronic muscle injury

  2020cites this paper
• Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy

  2020cites this paper
• High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

  2020cites this paper
• Preconditioning beef cattle for long-duration transportation stress with rumen-protected methionine supplementation: A nutrigenetics study

  2020cites this paper
• Redox-Dependent Regulation of Satellite Cells Following Aseptic Muscle Trauma: Implications for Sports Performance and Nutrition.

  2020cites this paper
• A mathematical model of healthy and dystrophic skeletal muscle biomechanics

  2020cites this paper
• Circulating markers of oxidative stress are associated with a muscle injury in patients with muscular dystrophy Duchenne.

  2020cites this paper
• Cellular Stress in the Pathogenesis of Muscular Disorders—From Cause to Consequence

  2020cites this paper
• Decreased smooth muscle function, peristaltic activity, and gastrointestinal transit in dystrophic (mdx) mice

  2020cites this paper
• Skeletal muscle DNMT3A plays a necessary role in endurance exercise by regulating oxidative capacity of red muscles

  2020cites this paper
• Demembranated Skeletal and Cardiac Fibers Produce Less Force with Altered Cross-Bridge Kinetics in a Mouse Model for Limb-Girdle Muscular Dystrophy 2i.

  2019cites this paper
• Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts.

  2019cites this paper
• Utrophin A Upregulation by FDA-Approved Drugs for the Treatment of Duchenne Muscular Dystrophy

  2019cites this paper
• Role of adiponectin in the metabolism of skeletal muscles in collagen VI–related myopathies

  2019cites this paper
• Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B

  2019cites this paper
• Antioxidant imbalance in the erythrocytes of Myotonic dystrophy Type 1 patients.

  2019cites this paper
• Dynamic thiol/disulphide homeostasis in children with Duchenne muscular dystrophy

  2019cites this paper
• An anti-RANKL treatment reduces muscle inflammation and dysfunction and strengthens bone in dystrophic mice.

  2019cites this paper
• Preclinical Models of Dystrophic Cardiomyopathy and Therapies for the Dystrophic Heart

  2019cites this paper
• Dystrophinopathy-associated dysfunction of Krebs cycle metabolism

  2018cites this paper
• Emerging roles of ER stress and unfolded protein response pathways in skeletal muscle health and disease

  2018cites this paper
• Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy—Implications for Therapies

  2018cites this paper
• Xanthine oxidase is hyper‐active in Duchenne muscular dystrophy

  2018cites this paper
• SMYD2 glutathionylation contributes to degradation of sarcomeric proteins

  2018cites this paper
• Development of Small Molecule Therapies Targeting Regeneration for the Treatment of Duchenne Muscular Dystrophy

  2018cites this paper
• Mitochondria-Targeted Antioxidants and Skeletal Muscle Function

  2018cites this paper
• Neopterin/7,8‐dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function

  2018cites this paper
• Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients

  2018cites this paper
• Muscle redox disturbances and oxidative stress as pathomechanisms and therapeutic targets in early-onset myopathies.

  2017cites this paper
• Emery-Dreifuss Muscular Dystrophy-Associated Mutant Forms of Lamin A Recruit the Stress Responsive Protein Ankrd2 into the Nucleus, Affecting the Cellular Response to Oxidative Stress

  2017cites this paper
• Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.

  2017cites this paper
• Redox Control of Skeletal Muscle Regeneration

  2017cites this paper
• Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein

  2017cites this paper
• Cysteinet Dysregulation in Muscular Dystrophies: A Pathogenic Network Susceptible to Therapy.

  2017cites this paper
• Efeitos cardiovasculares da associação do hormônio tireoidiano e do treinamento físico na cardiotoxicidade induzida por doxorrubicina em ratos

  2017cites this paper
• Characterising and evaluating the efficacy of metabolic therapies for the treatment of Duchenne Muscular Dystrophy

  2017cites this paper
• Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy

  2017cites this paper
• Effects of hyperlipidemia on dysferlin- and dystrophin-deficient muscular dystrophies in double-disease mouse models

  2017cites this paper
• Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy

  2017cites this paper
• Insights into the Pathogenic Secondary Symptoms Caused by the Primary Loss of Dystrophin

  2017cites this paper
• Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B[S]

  2017cites this paper
• L-carnitine protects C2C12 cells against mitochondrial superoxide overproduction and cell death

  2017cites this paper
• Alterações bioquímicas, moleculares, histológicas e comportamentais na prole de ratas Wistar submetidas à hipermetioninemia gestacional

  2017cites this paper
• Muscle redox disturbances and oxidative stress as pathomechanisms and therapeutic targets in early-onset myopathies

  2017cites this paper
• Enhanced Energetic State and Protection from Oxidative Stress in Human Myoblasts Overexpressing BMI1

  2017cites this paper
• Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture

  2016cites this paper
• Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress.

  2016cites this paper
• Cardiotoxicity of chemotherapy drugs and possible protective effects of physical exercise: a literature review

  2016cites this paper
• Dystrophin Degradation in Skeletal Muscles with Lipid Enrichment in Cattle

  2016cites this paper
• A Simplified Approach for the Direct Detection of Protein Oxidation in Muscle Using In-Gel and Microplate Assays

  2016cites this paper
• Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy

  2016cites this paper
• Improving Stem Cell-Based Therapy and Developing a Novel Gene Therapy Approach for Treating Duchenne Muscular Dystrophy (DMD)

  2016cites this paper
• The weak combined magnetic field, tuned to ion parametric resonance for Ca2+, stimulates dystrophin synthesis in the skeletal muscles of mdx mice subjected to cell therapy

  2016cites this paper
• Role of oxidised protein repair for skeletal muscle homeostasis

  2016cites this paper
• Preventive effect of dietary quercetin on disuse muscle atrophy by targeting mitochondria in denervated mice.

  2016cites this paper
• Practical Nutrition Guidelines for Individuals with Duchenne Muscular Dystrophy

  2016cites this paper
• Impact d’un traitement antioxydant sur le transfert de gène par un vecteur AAVr dans un modèle murin de la dystrophie musculaire de Duchenne

  2016cites this paper
• Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy.

  2016cites this paper
• Redox imbalance in peripheral blood of type 1 myotonic dystrophy patients

  2016cites this paper
• Going retro: Oxidative stress biomarkers in modern redox biology.

  2016cites this paper
• Porcine models of muscular dystrophy.

  2015cites this paper
• Structural origin of the drastic modification of second harmonic generation intensity pattern occurring in tail muscles of climax stages xenopus tadpoles.

  2015cites this paper
• DETERMINATION OF OXIDATIVE STRESS FACTORS IN PATIENTS WITH HEREDITARY MUSCLE DISEASES: ONE POSSIBLE DIAGNOSTIC AND OPTIONAL MANAGEMENT OF THE PATIENTS

  2015cites this paper
• Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice.

  2015cites this paper
• Gestational hypermethioninaemia alters oxidative/nitrative status in skeletal muscle and biomarkers of muscular injury and inflammation in serum of rat offspring

  2015cites this paper
• Muscle MRI in Duchenne and Becker muscular dystrophy

  2015cites this paper
• Reduction of Oxidative Damage and Inflammatory Response in the Diaphragm Muscle of mdx Mice Using Iron Chelator Deferoxamine

  2015cites this paper
• The Role of Membrane Lipid Composition on Skeletal Muscle Damage in the Rodent Model of Duchenne Muscular Dystrophy

  2015cites this paper
• Redox Characterization of Functioning Skeletal Muscle

  2015cites this paper
• Neurotrophins, cytokines, oxidative parameters and funcionality in Progressive Muscular Dystrophies.

  2015cites this paper
• Impact of methionine oxidation on calmodulin structural dynamics.

  2015cites this paper
• Oxidation as an important factor of protein damage: Implications for Maillard reaction

  2015cites this paper
• Remodeling of Mitochondrial Flashes in Muscular Development and Dystrophy in Zebrafish

  2015cites this paper
• Aquapuncture Using Stem Cell Therapy to Treat Mdx Mice

  2015cites this paper
• The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes

  2015cites this paper
• Epigenetic Mechanisms for Klotho Gene Silencing in Dystrophic Muscle

  2015cites this paper
• The effect of NADP+ on cardiomyocyte electrophysiological properties of C57BL/6 and mdx mice

  2014cites this paper
• Involvement of oxidative stress, nuclear factor kappa B and the ubiquitin proteasomal pathway in dysferlinopathy.

  2014cites this paper
• Dystropathology Increases Energy Expenditure and Protein Turnover in the Mdx Mouse Model of Duchenne Muscular Dystrophy

  2014cites this paper
• Altered cross-bridge properties in skeletal muscle dystrophies

  2014cites this paper